Literature DB >> 12033720

Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study.

Caroline Ross1, Paul Davies, William Whitehouse.   

Abstract

The study aim was to quantify melatonin-associated improvement in sleep by means of a parent-completed sleep diary during routine outpatient activity. An investigation into sleep disturbance was made at neurology outpatient appointments. Those parents who identified a problem were asked to complete a sleep diary, after which treatment was initiated. The first week of the diary was completed before treatment, the second when established on the maximum dose of melatonin required. Forty-nine patients (26 males, 23 females) aged from one to 13 years, were treated between 1997 and 1998: 28 of these returned interpretable diaries. In a further 18 patients, an assessment could be made of the usefulness of the treatment. Patients were fairly typical of those attending a tertiary centre, the most common primary diagnosis being epilepsy (n=26). Only seven patients were visually impaired. Of the 46 patients who were assessed, 34 showed an improvement. No adverse effects were attributed to the treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033720     DOI: 10.1017/s0012162201002171

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

Review 1.  Sleep in children with autism spectrum disorders.

Authors:  Kyle P Johnson; Beth A Malow
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

2.  An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism.

Authors:  F Giannotti; F Cortesi; A Cerquiglini; P Bernabei
Journal:  J Autism Dev Disord       Date:  2006-08

Review 3.  Sleep and childhood epilepsy.

Authors:  S Aneja; M Gupta
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

Review 4.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

5.  Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.

Authors:  Mansour Tobaiqy; Derek Stewart; Peter J Helms; Justin Williams; Jackie Crum; Christopher Steer; James McLay
Journal:  Drug Saf       Date:  2011-03-01       Impact factor: 5.606

6.  The Use of Melatonin by Children: Parents' Perspectives.

Authors:  Amy Y Waldron; M Joy Spark; Christina M Dennis
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

Review 7.  Does melatonin affect epileptic seizures?

Authors:  Siddharth Jain; Frank M C Besag
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

8.  Sleep in children with autism spectrum disorders.

Authors:  Kyle P Johnson; Beth A Malow
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

Review 9.  Medication for sleep-wake disorders.

Authors:  G Stores
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

Review 10.  Analgesic, anxiolytic and anaesthetic effects of melatonin: new potential uses in pediatrics.

Authors:  Lucia Marseglia; Gabriella D'Angelo; Sara Manti; Salvatore Aversa; Teresa Arrigo; Russel J Reiter; Eloisa Gitto
Journal:  Int J Mol Sci       Date:  2015-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.